Related Experiment Video
Updated: May 12, 2026

In vivo Liver Endocytosis Followed by Purification of Liver Cells by Liver Perfusion
Published on: November 10, 2011
Strategies to overcome hepatic clearance of endogenous proteins - molecular and formulation approaches
Kirstin Meiners1, Tobias Stepic1, Lorenz Meinel1,2
1Institute of Pharmacy and Food Chemistry, University of Würzburg Am Hubland Würzburg 97074 Germany Tessa.luehmann@uni-wuerzburg.de.
Abstract:
The medical use of biologics is often limited by rapid elimination from circulation. This review explores formulation strategies for enhancing the pharmacokinetic profiles of therapeutic proteins with hepatic clearance as a major route of elimination. Pharmacokinetic and hepatic clearance mechanisms of selected endogenous proteins - tissue-type plasminogen activator, glucagon-like peptide 1, insulin and interferon-β - are detailed and discussed. Molecular optimization and formulation strategies for these four biologics highlight the overcoming of pharmacokinetic limitations resulting in successful clinical approvals. The assessment of genetic engineering, bioconjugation, fusion proteins, and protein drug delivery systems for their potential to prolong serum half-life should facilitate prospective development of pharmacological active macromolecules failing due to their rapid elimination in the liver. Overall, this review elucidates the relationships among formulation design, protein structure, and hepatic clearance, and their combined impact on therapeutic efficacy.
Related Concept Videos
Hepatic Drug Clearance: Effect of Protein Binding
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance
Most drugs undergo restrictive clearance, which is proportional to the...
Hepatic Drug Clearance: Role of Transporters
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Bioavailability Enhancement: Drug Permeability Enhancement
